Some studies have revealed that TRIM21 exerts tumor-suppressive effects in certain cancers (for instance, breast cancer, renal cell carcinoma, and cervical cancer) [7–9], while in other types of cancer (such as glioma, nasopharyngeal carcinoma, and liver cancer), it was reported to promote tumor growth [10–12]. This evidence concerns the gene TRIM21 and neoplasm.